# Founded by two brothers who believe the whole qPCR workflow belongs in one place.

> Founded in Belgium by Jan and Ward Hellemans. Jan published the qBase method in 2007; Ward was product manager of qbase+. Owned by founders and private investors.

Source: https://clarida.bio/about

About

Clarida builds analysis and workflow software for qPCR, from Belgium. Ask us something and a founder answers.

01 Our story

## How Clarida started.

In 2007, Jan Hellemans co-founded Biogazelle, which built the qbase+ software on his qBase method. Ward Hellemans joined in 2011, first in user support and later as product manager of qbase+.

Working with those labs, we saw where the time went: an Excel template to plan the run, the cycler's software to collect the data, separate tools for analysis and statistics, a report written by hand. Data moved between them by copy and paste.

We started Clarida in 2025 to keep one record of each experiment, from its design to the report. The company was registered in March 2026.

[Read the Clarida manifesto](https://clarida.bio/blog/the-clarida-manifesto) · [What happened to qbase+](https://clarida.bio/qbase-plus/what-happened)

02 The people

## Founders and a scientific advisor.

### Founders

- Jan Hellemans

  Co-founder

  Leads the science and the methods at Clarida. Published the qBase method in 2007 and co-authored the MIQE guidelines.
  - [qBase](https://doi.org/10.1186/gb-2007-8-2-r19) (2007) cited 4,019 times
  - [MIQE](https://doi.org/10.1373/clinchem.2008.112797) (2009) cited 16,247 times

  [LinkedIn](https://www.linkedin.com/in/jhellema/)
- Ward Hellemans

  Co-founder

  Runs the product and the company side of Clarida.

  [LinkedIn](https://www.linkedin.com/in/wardhellemans/)

### Scientific advisor

- Jo Vandesompele

  Scientific advisor

  Professor at Ghent University. Published geNorm, the method for choosing reference genes and how many to use. Co-authored the MIQE guidelines and MIQE 2.0, their 2025 update.
  - [geNorm](https://doi.org/10.1186/gb-2002-3-7-research0034) (2002) cited 20,009 times
  - [qBase](https://doi.org/10.1186/gb-2007-8-2-r19) (2007) cited 4,019 times
  - [MIQE](https://doi.org/10.1373/clinchem.2008.112797) (2009) cited 16,247 times
  - [MIQE 2.0](https://doi.org/10.1093/clinchem/hvaf043) (2025) cited 315 times

  [LinkedIn](https://www.linkedin.com/in/jvdesomp/)

Citation counts: [OpenAlex](https://openalex.org/), October 23, 2026.

03 How we work

## High quality, open science with fewer apps and clicks.

- ### Quality

  The calculations follow published methods, such as geNorm and qBase. Each result keeps the settings that produced it, so you can trace it back to the run.

  [Open the methods library](https://clarida.bio/methods)
- ### Openness

  Export any experiment as RDML or an Excel file, on every plan. The free tools, training videos and methods library are open to anyone.

  [See the free tools](https://clarida.bio/tools)
- ### Fewer apps and clicks

  Plan the plate, import the run, analyze it and write the report in one place, so nothing is copied between programs.

  [See how it works](https://clarida.bio/qpcr)

04 The company

## No reagent, kit or instrument maker owns part of Clarida.

Clarida is owned by its founders and private investors, with support from [VLAIO](https://www.vlaio.be/en), the Flemish agency for innovation and entrepreneurship.

- **Legal name**: Clarida BV
- **Registered**: March 26, 2026
- **Registered office**: Krombrugge 2, 9820 Merelbeke-Melle, Belgium
- **VAT and company number**: BE 1036.065.215
- **Email**: [info@clarida.bio](mailto:info@clarida.bio)

[See open roles](https://clarida.bio/jobs)

## See the work for yourself.

Start free on a run you already have, or book a call with one of us. 4 experiments in your first month, then 2 a month. No card.

[Start free](https://app.clarida.bio/login) · [Talk to a founder](https://clarida.bio/talk-to-us)
